Uterine Serous Carcinoma
Oncology·MeSH: Cystadenocarcinoma, Serous
4 drugs in development·3 companies·1 clinical trial
Drug Pipeline by Phase
Phase 3(2)
Phase 1(1)
| Drug | Company |
|---|---|
| APR-1051 | Aprea Therapeutics, Inc. (APRE) |
Preclinical(1)
| Drug | Company |
|---|---|
| sw-3431 | SpringWorks Therapeutics, Inc. (SWTX) |
Compare drugs
Frequently asked questions
How many drugs are in development for Uterine Serous Carcinoma?
BioSniper tracks 4 drugs in development for Uterine Serous Carcinoma across 3 companies.
How many clinical trials target Uterine Serous Carcinoma?
There are 1 clinical trial targeting Uterine Serous Carcinoma tracked by BioSniper.
Deep-dive into Uterine Serous Carcinoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis